mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
AMG-706 |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.046 |
0.4 |